AVIA Biosystems Automates Protein Stability Studies
October 1, 2013
Norton, Mass. – The new Model 2304 Automated Protein Denaturation System completely automates protein stability determinations using chemical denaturation, and is both the first instrument of its kind and the first instrument to be introduced by AVIA Biosystems of Norton, Mass. (www.aviabiosystems.com). Developed to facilitate the formulation of biologics in a safe and stable form, [...]
NanoString Technologies, Inc. and Fluidigm Corporation Settle Lawsuits
October 1, 2013
SEATTLE -- NanoString Technologies, Inc. (Nasdaq:NSTG) and Fluidigm Corporation (Nasdaq:FLDM) have agreed to settle lawsuits filed by Fluidigm in the United States and Singapore. In the U.S. case, Fluidigm charged NanoString with false advertising, unfair competition, and unlawful trade practices based on a comparison study of NanoString's Single Cell Gene Expression Assay on the nCounter® [...]
Emerson targets greatly expanded market for business critical applications
October 1, 2013
AUSTIN, TEXAS -- Emerson Process Management, a global business of Emerson (NYSE: EMR), is introducing an expanded product portfolio to address an untapped market for intelligent sensors in process manufacturing and production operations. This expanded “pervasive sensing” market extends the company’s focus beyond traditional process control and safety systems to now address customers’ need for [...]
Implant Sciences’ QS-B220 Explosives Trace Detector Receives STAC Certification in France
October 1, 2013
WILMINGTON, Mass. -- Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, announced today that its TSA-approved QS-B220 desktop explosives trace detector (ETD) has been certified by Service Technique de l'Aviation Civile (STAC) in France. The QS-B220 is now certified for purchase and deployment to [...]
First urine-based cancer mutation monitoring test available from Trovagene
October 1, 2013
SAN DIEGO -- Trovagene, Inc. (NASDAQ: TROV), a developer of cell-free molecular diagnostics, today announced availability of the first urine test for cancer mutation monitoring through the company's CLIA laboratory. The robustness of Trovagene's ultra-sensitive assay procedure has been demonstrated for detection of the BRAF V600E mutation from cell-free DNA in urine. This mutation commonly [...]
September 30, 2013
NEW YORK — Exosome Diagnostics today announced that it has selected Cedars-Sinai Medical Center to participate in an early technology access program for use of exosome RNA biofluid extraction kits for biomarker discovery in neo-natal and other disease settings. "The ability to monitor patients, particularly extreme premature infants, using real-time biofluid based genetics tests, may [...]
Life Technologies and Advanced Cell Diagnostics Sign Global Distribution Agreement
September 30, 2013
CARLSBAD, Calif. -- Life Technologies Corporation (NASDAQ: LIFE) and Advanced Cell Diagnostics, Inc. (ACD), a leader in the field of molecular pathology and developer of cell and tissue-based analysis tools, today announced a global distribution agreement by which Life will distribute ACD's fluorescent RNAscope® portfolio of probes and kits to the research market through its [...]
Transgenomic Announces Executive Changes
September 30, 2013
OMAHA, Neb. -- Transgenomic, Inc. (OTCBB: TBIO), a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through diagnostic tests as well as clinical and research services, today announced that Paul Kinnon has been named President, Chief Executive Officer and a Director, replacing Craig J. Tuttle, effective today. Mr. Kinnon brings over [...]
Particle Measuring Systems Expands Technology Portfolio
September 30, 2013
Boulder, CO -- Particle Measuring Systems is pleased to announce the purchase of Naneum Ltd. This latest acquisition expands their broad suite of products and strengthens their experience related to key emerging technologies, supporting the International Technology Roadmap for Semiconductors (ITRS). Addition of Naneum’s technologies to their extensive experience in micro-contamination monitoring promises major advancements [...]
SQI Diagnostics Announces Changes to Its Board of Directors
September 30, 2013
TORONTO -- SQI Diagnostics’ Inc. (TSX-V: SQD) Board of Directors is pleased to announce the appointment of Andrew Morris, President and CEO of SQI Diagnostics to the Board of Directors. Andrew Morris has been with SQI for over nine years and acted as the Company’s Chief Financial Officer prior to being promoted to President and [...]
